Clinical Prescribing Information for Omeprazole
Omeprazole Dosing According to BNFC Guidelines
Omeprazole dosing follows specific BNFC protocols depending on the condition being treated. For gastro-oesophageal reflux disease (GORD), the standard adult dose is 20mg once daily, taken 30-60 minutes before food. Severe cases may require 40mg daily under specialist guidance. Paediatric dosing requires careful weight-based calculations as outlined in current BNFC recommendations.
Contraindications and Precautions
BNFC guidance highlights important contraindications including hypersensitivity to substituted benzimidazoles and caution in patients with severe hepatic impairment. Long-term use requires monitoring for hypomagnesaemia, vitamin B12 deficiency, and increased fracture risk. Omeprazole may interact with clopidogrel, reducing its antiplatelet effects.
Available Formulations
EverydayMeds stocks multiple omeprazole formulations including standard 20mg capsules, Losec MUPS tablets for easier swallowing, and alternative PPIs such as lansoprazole 15mg capsules and pantoprazole 20mg tablets. Each formulation offers specific advantages for different patient needs and swallowing difficulties.
Monitoring Requirements
BNFC emphasises regular review of long-term PPI therapy. Patients should be assessed for symptom resolution after 4-8 weeks, with dose reduction or discontinuation considered where appropriate. Monitoring includes checking for drug interactions, particularly with warfarin, digoxin, and certain antifungal medications.
Treatment Duration Guidelines
Initial treatment courses typically last 4-8 weeks for GORD or peptic ulcer healing. Maintenance therapy may be necessary for severe cases, but BNFC guidance recommends using the lowest effective dose for the shortest duration possible. Regular medication reviews ensure optimal treatment outcomes whilst minimising potential adverse effects.
